Could these ASX stocks really be set to double after crashing this week?

These companies are expected to rebound.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) has fallen this week as eyes stay firmly placed on the conflict between the US and Iran.

According to the ABC, both sides maintain there is a ceasefire in place and as a second round of peace talks lingers.

This is despite the US announcing ships from all Iranian ports were under blockade. 

It appears this grey area is weighing on investor sentiment. 

On the positive side, during the week, several ASX shares received updated guidance from brokers. 

Some of these shares are expected to double in the next 12 months after experiencing heavy sell-offs recently.

Here are some of the latest recommendations. 

A woman is excited as she reads the latest rumour on her phone.

Image source: Getty Images

Cochlear Ltd (ASX: COH)

Cochlear shares have been some of the most heavily sold off in 2026. 

The ASX healthcare stock fell a further 4% yesterday, and is now down 63% this year. 

Most of this damage was done this week after the company significantly downgraded its earnings guidance.

So where does this leave the stock now?

Some brokers believe the sell-off has been overdone, creating a buy-low opportunity. 

This includes a recent buy rating from UBS analyst David Low.

Low has a 12-month target of $302 on this ASX 200 healthcare share.

This implies more than 200% upside over the next 12 months.

Buyers should be aware this optimism isn't reciprocated everywhere, as Morgans rates the company as a hold. 

Black Pearl Group Ltd (ASX: BPG)

Black Pearl Group is a recently listed data technology platform provider. 

Bell Potter has been quick to get behind these ASX shares, with consistent buy ratings throughout 2026. 

This week, the broker retained its speculative buy rating on the ASX tech stock with an improved price target of $1.82 (from $1.76).

Yesterday, these ASX shares fell more than 12%, which has created even more upside for optimistic investors. 

It closed trading yesterday at 68 cents per share. 

If it reaches the price target set by Bell Potter, that would be a 168% rise. 

Generation Development Group Ltd (ASX: GDG)

Another ASX stock that fell significantly this week was Generation Development Group. 

The ASX financials company provides investment bonds and investment-linked lifetime annuities which offer innovative and tax-efficient solutions for wealth accumulation, estate planning and generating regular income in retirement.

Its share price crashed 22% on Wednesday following its March 2026 quarterly update.

Following this result, the team at Bell Potter reduced its price target on this ASX 200 stock to $6.20 (previously $7.40). 

However from yesterday's closing price of $3.60, this updated target indicates an upside potential of 72%. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear and Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »

A man in a sweatshirt holds two different phones to compare telco services.
Broker Notes

Forget Rio Tinto and buy this ASX copper share

Bell Potter thinks this stock could be a good alternative to the mining giant.

Read more »

A happy couple drinking red wine in a vineyard.
Broker Notes

2 ASX 200 shares newly upgraded this week

After major company news this week, one stock fell 39% while the other spiked 17%.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on CBA shares

A leading analyst forecasts headwinds for CBA shares. But why?

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »